| Primary |
| Epilepsy |
52.2% |
| Convulsion |
23.9% |
| Partial Seizures |
3.9% |
| Pregnancy |
2.4% |
| Grand Mal Convulsion |
2.4% |
| Status Epilepticus |
2.2% |
| Complex Partial Seizures |
1.8% |
| Hypertension |
1.5% |
| Partial Seizures With Secondary Generalisation |
1.3% |
| Prophylaxis |
1.2% |
| Myoclonic Epilepsy |
1.0% |
| Depression |
1.0% |
| Simple Partial Seizures |
0.9% |
| Convulsion Prophylaxis |
0.8% |
| Glioblastoma |
0.7% |
| Pain |
0.6% |
| Petit Mal Epilepsy |
0.5% |
| Glioblastoma Multiforme |
0.5% |
| Hypothyroidism |
0.5% |
| Myoclonus |
0.5% |
|
| Pregnancy |
11.4% |
| Thrombocytopenia |
11.3% |
| Convulsion |
8.6% |
| Maternal Drugs Affecting Foetus |
6.5% |
| Status Epilepticus |
5.6% |
| Drug Exposure During Pregnancy |
5.5% |
| Somnolence |
4.8% |
| Vomiting |
4.8% |
| Weight Decreased |
4.4% |
| Suicidal Ideation |
4.2% |
| Product Substitution Issue |
4.0% |
| Death |
3.8% |
| Premature Baby |
3.8% |
| Pancytopenia |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Suicide Attempt |
3.4% |
| Leukopenia |
3.4% |
| Platelet Count Decreased |
2.7% |
| Neutropenia |
2.3% |
| Ventricular Septal Defect |
2.2% |
|
| Secondary |
| Epilepsy |
37.5% |
| Convulsion |
25.5% |
| Product Used For Unknown Indication |
9.1% |
| Drug Use For Unknown Indication |
5.7% |
| Status Epilepticus |
2.9% |
| Partial Seizures |
2.9% |
| Grand Mal Convulsion |
2.5% |
| Complex Partial Seizures |
2.4% |
| Pregnancy |
1.6% |
| Hypertension |
1.4% |
| Prophylaxis |
1.2% |
| Pain |
1.2% |
| Foetal Exposure During Pregnancy |
1.1% |
| Depression |
1.0% |
| Bipolar Disorder |
0.9% |
| Encephalitis |
0.7% |
| Drug Exposure During Pregnancy |
0.7% |
| Hiv Infection |
0.6% |
| Myoclonic Epilepsy |
0.6% |
| Glioblastoma Multiforme |
0.6% |
|
| Convulsion |
11.4% |
| Weight Decreased |
9.2% |
| Thrombocytopenia |
8.3% |
| Somnolence |
6.7% |
| Suicidal Ideation |
6.1% |
| Status Epilepticus |
6.1% |
| Pregnancy |
6.0% |
| Vomiting |
4.7% |
| Premature Baby |
4.5% |
| Weight Increased |
4.3% |
| Urinary Tract Infection |
3.8% |
| White Blood Cell Count Decreased |
3.6% |
| Drug Exposure During Pregnancy |
3.4% |
| Tremor |
3.4% |
| Epilepsy |
3.3% |
| Maternal Drugs Affecting Foetus |
3.2% |
| Rash |
3.1% |
| Toxicity To Various Agents |
3.0% |
| Treatment Noncompliance |
3.0% |
| Wrong Technique In Drug Usage Process |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
13.7% |
| Epilepsy |
11.9% |
| Convulsion |
11.7% |
| Glioblastoma Multiforme |
4.6% |
| Multiple Sclerosis |
3.9% |
| Hypertension |
3.5% |
| Pain |
3.3% |
| Glioblastoma |
3.0% |
| Prophylaxis |
2.8% |
| Depression |
2.5% |
| Anxiety |
1.5% |
| Infantile Spasms |
1.4% |
| Nausea |
1.4% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Asthma |
1.0% |
| Constipation |
1.0% |
| Diabetes Mellitus |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Insomnia |
0.9% |
|
| Convulsion |
17.3% |
| Vomiting |
11.0% |
| Weight Decreased |
6.4% |
| Urinary Tract Infection |
5.8% |
| Death |
5.5% |
| Drug Ineffective |
4.8% |
| Somnolence |
4.4% |
| Pneumonia |
4.2% |
| Thrombocytopenia |
4.2% |
| Epilepsy |
4.0% |
| Rash |
3.9% |
| Weight Increased |
3.9% |
| Tremor |
3.9% |
| Pyrexia |
3.6% |
| White Blood Cell Count Decreased |
3.2% |
| Pulmonary Embolism |
3.0% |
| Grand Mal Convulsion |
2.9% |
| Status Epilepticus |
2.8% |
| Stevens-johnson Syndrome |
2.7% |
| Syncope |
2.6% |
|
| Interacting |
| Epilepsy |
17.4% |
| Drug Use For Unknown Indication |
13.1% |
| Convulsion |
9.9% |
| Hypertension |
9.2% |
| Infection Prophylaxis |
8.5% |
| Prophylaxis |
5.7% |
| Lower Respiratory Tract Infection |
4.3% |
| Product Used For Unknown Indication |
3.9% |
| Constipation |
3.2% |
| Glaucoma |
3.2% |
| Pain |
2.8% |
| Cerebrovascular Accident |
2.1% |
| Chronic Lymphocytic Leukaemia |
2.1% |
| Colonoscopy |
2.1% |
| Diabetes Mellitus |
2.1% |
| Iron Deficiency Anaemia |
2.1% |
| Myoclonus |
2.1% |
| Neuropathy Peripheral |
2.1% |
| Partial Seizures |
2.1% |
| Atrial Fibrillation |
1.8% |
|
| Drug Interaction |
24.3% |
| Liver Function Test Abnormal |
11.4% |
| Paraesthesia |
10.0% |
| Vomiting |
8.6% |
| Epilepsy |
7.1% |
| Somnolence |
7.1% |
| Paranoia |
4.3% |
| Weight Decreased |
4.3% |
| Neutropenia |
2.9% |
| Personality Change |
2.9% |
| Suicidal Ideation |
2.9% |
| Syncope |
2.9% |
| Alanine Aminotransferase Increased |
1.4% |
| Blood Alkaline Phosphatase Increased |
1.4% |
| Coma |
1.4% |
| Drug Withdrawal Syndrome |
1.4% |
| Dyspnoea |
1.4% |
| Fall |
1.4% |
| Food Interaction |
1.4% |
| Gait Disturbance |
1.4% |
|
